Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEVEMIR
- A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It
- Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin
- GLP-1/Basal Insulin Combination Therapy
- Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
- Sitagliptin in Non-Diabetic Patients Undergoing General Surgery
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)
- Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM
- Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors
- Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes
- An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
- A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Withou
- Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
- Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
- Efficacy and Safety of Levemir® Used as Basal Insulin
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
- Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
- Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos
- The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
- Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
- An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus
- An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime
- Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
- Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
- Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- New Onset Type 1 Diabetes: Role of Exenatide
- Insulin Detemir in Obesity Management
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
- Cystic Fibrosis - Insulin Deficiency, Early Action
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- INSUlin Regimens and VASCular Functions
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
- Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
- Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues
- Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
- Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment
- Levemir-Body Composition and Energy Metabolism
- Observational Study on Levemir® in Obese Diabetic Patients
- Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia
- An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries
- Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes
- A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
- Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
- Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
- An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes
- Detemir Energy Expenditure Study
- Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes
- Observational Study on Safety of Self-titration of Once Daily Levemir®
- An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
- Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
- Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir
- Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
- Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
- Observational Study to Evaluate the Safety of Levemir® in Diabetes
- Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes
- Observational Study to Evaluate the Safety While Using Levemir®
- Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
- Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
- Endothelial Effects of Basal Insulin: Detemir Versus Glargine
- An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment
- Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics
- Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
- Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes
- Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
- Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
- Observational Study of Patients With Diabetes Using Levemir® FlexPen®
- Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
- Observational Study to Evaluate the Safety of Levemir® in Diabetes
- Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
- Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
- The Copenhagen Insulin and Metformin Therapy Trial
- Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
- Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
- Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
- Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
- Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- Basal Insulins - Pharmacodynamics
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
- Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial
- Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
- Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
- Sub-Cutaneous Insulin in Hyperglycaemic Emergencies
- Lantus Versus Levemir Treat-To-Target
- Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
- Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Clinical trials list
click for details